WeVote
Log In

Bill

Bill

HR 146

Gallois, Gina; commend

2025-2026 Regular Session Introduced by Karen Lupton and 1 co-sponsor

HR 146 establishes a working group to tackle pharmacy reimbursement issues, aiming to propose legislative solutions for fair compensation and improved access to medications.

House Read and Adopted
0
WeVote Research Nonpartisan
Bill Summary · HR 146

Summary of HR 146: Pharmacy Reimbursement Working Group

Bill Overview

Bill Number: HR 146
Title: Requesting the Department of Commerce and Consumer Affairs to Establish and Convene a Pharmacy Reimbursement Working Group to Explore and Propose Legislation for the 2026 Legislative Session
Status: Referred to HLT, CPC, referral sheet 22
Introduced: January 03, 2025
Classification: Resolution
Subject: Pharmacy Reimbursement Working Group

Purpose and Intent

The primary purpose of HR 146 is to establish a working group focused on pharmacy reimbursement issues. The bill aims to address the complexities and challenges surrounding how pharmacies are reimbursed for the medications and services they provide. By convening this group, the bill seeks to gather insights and propose legislative solutions that can be presented in the 2026 legislative session.

Key Provisions

  • Establishment of a Working Group: The bill requests the Department of Commerce and Consumer Affairs to form a Pharmacy Reimbursement Working Group.
  • Exploration of Issues: The working group will explore various aspects of pharmacy reimbursement, including current practices, challenges faced by pharmacies, and potential improvements.
  • Legislative Proposals: The group is tasked with developing proposals for legislation that could enhance the reimbursement process for pharmacies, ensuring they are fairly compensated for their services.

Affected Parties

  • Pharmacies: The primary stakeholders affected by this bill are pharmacies, which may benefit from improved reimbursement practices.
  • Consumers: Patients who rely on pharmacies for medications and health services may also be impacted by changes in reimbursement policies, potentially affecting the availability and affordability of medications.
  • Legislators and Policymakers: The outcomes of the working group’s findings will provide valuable information for lawmakers as they consider future legislation related to pharmacy reimbursement.

Procedural Timeline

  • January 03, 2025: The bill was introduced in the House and referred to the House Committee on Financial Services.
  • March 07, 2025: The bill was offered for consideration.
  • March 14, 2025: The bill was referred to the HLT and CPC committees, as noted in referral sheet 22.

Related Legislation

  • HCR 152: This is a companion resolution related to HR 146, which may address similar issues or provide additional context for the working group's objectives.

Conclusion

HR 146 represents a proactive approach to addressing pharmacy reimbursement challenges by forming a dedicated working group. The outcomes of this initiative could lead to significant legislative proposals aimed at improving the financial sustainability of pharmacies and ensuring better access to medications for consumers in the upcoming legislative session.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.